Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
This completed trial assessed the vascular and metabolic effects of sunitinib in patients with metastatic renal cell carcinoma, focusing on …
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial update for BMS-936558 (MDX-1106) in advanced/metastatic clear-cell renal cell carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer [Phase 1]
A Phase 1 clinical trial evaluating the safety and immunologic response of COMBIG-DC in patients with metastatic renal cell carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study exploring trebananib in combination with temsirolimus for adults with metastatic or unresectable solid tumors, including neuro…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging
This clinical trial update reports on completed research evaluating whether functional imaging can predict response to anti-angiogenic thera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating sorafenib in elderly patients with metastatic renal cell carcinoma, with the study subsequently terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: Regulatory Post Marketing Surveillance Study on Nexavar®
A completed regulatory post-marketing surveillance study evaluating Nexavar (sorafenib) safety in patients with hepatocellular carcinoma and…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating Velcade (bortezomib) with sorafenib in unresected or metastatic renal cell carcinoma was terminated; results were…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat in combination with bevacizumab for unresectable or metastatic renal cell carcinoma has completed with…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating CVX-060 in combination with sunitinib for advanced renal cell carcinoma was terminated; results were posted in 2015…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer [Phase 2]
Phase 2 trial update for low dose naltrexone in metastatic melanoma, castration-resistant prostate cancer, and renal cancer; study terminate…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating sorafenib with palliative radiotherapy for renal cell carcinoma with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating the combination of axitinib and everolimus in patients with malignant advanced solid tumors, including renal cell…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma [Phase 2, Phase 3]
A Phase 2/3 trial compares Naptumomab estafenatox plus interferon-alpha versus interferon-alpha alone in advanced renal cell carcinoma; the …
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: The Intrathecal Morphine for Nephrectomy [NA]
Completed clinical trial evaluating intrathecal morphine for pain management during nephrectomy in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors [Phase 2]
Phase 2 study evaluating activated allogeneic lymphocytes to induce a graft-versus-tumor effect in metastatic solid tumors, including metast…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma [Phase 2, Phase 3]
This randomized trial compares spinal anesthesia to traditional epidural anesthesia for perioperative and postoperative pain control in pati…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer [NA]
The clinical trial evaluating diagnostic value of molecular markers in renal (kidney) cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). [Phase 2]
Phase 2 trial update evaluating Avastin (bevacizumab) in combination with low-dose interferon in metastatic renal cell carcinoma, with resul…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer [Phase 1, Phase 2]
Clinical trial update reporting completion of a Phase 1/2 study that evaluated fluorouracil with low-dose suramin as chemosensitization for …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: microRNA Expression in Renal Cell Carcinoma
A completed clinical trial from Sun Yat-sen University investigated microRNA expression in renal cell carcinoma and has an update available.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of pazopanib in previously treated patients with metastatic renal cell carcinoma has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)
This completed observational pilot trial evaluated the feasibility of conducting genome-wide association studies using subject-provided info…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial investigating bevacizumab, sorafenib tosylate, and temsirolimus in metastatic kidney cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Sutent Rechallenge In mRCC Patients
The document reports the completion and posted results of a clinical trial evaluating rechallenge with Sutent (sunitinib) in patients with m…